Argentina Heparin Market Size & Outlook, 2023-2030

The heparin market in Argentina is expected to reach a projected revenue of US$ 45.0 million by 2030. A compound annual growth rate of 3.9% is expected of Argentina heparin market from 2024 to 2030.
Revenue, 2023 (US$M)
$34.3
Forecast, 2030 (US$M)
$45.0
CAGR, 2024 - 2030
4%
Report Coverage
Argentina

Argentina heparin market highlights

  • The Argentina heparin market generated a revenue of USD 34.3 million in 2023 and is expected to reach USD 45.0 million by 2030.
  • The Argentina market is expected to grow at a CAGR of 3.9% from 2024 to 2030.
  • In terms of segment, bovine was the largest revenue generating source in 2023.
  • Porcine is the most lucrative source segment registering the fastest growth during the forecast period.


Heparin market data book summary

Market revenue in 2023USD 34.3 million
Market revenue in 2030USD 45.0 million
Growth rate3.9% (CAGR from 2023 to 2030)
Largest segmentBovine
Fastest growing segmentPorcine
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPorcine, Bovine
Key market players worldwidePfizer Inc, Sanofi SA, Aspen Pharmacare Holdings Ltd, Fresenius SE & Co KGaA, Novartis AG ADR, GSK PLC ADR, Dr. Reddy’s Laboratories, LEO Pharma, B. Braun Medical


Other key industry trends

  • In terms of revenue, Argentina accounted for 0.5% of the global heparin market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil heparin market is projected to lead the regional market in terms of revenue in 2030.
  • Mexico is the fastest growing regional market in Latin America and is projected to reach USD 92.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Heparin Market Companies

Name Profile # Employees HQ Website

Argentina heparin market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heparin market will help companies and investors design strategic landscapes.


Bovine was the largest segment with a revenue share of 67.93% in 2023. Horizon Databook has segmented the Argentina heparin market based on porcine, bovine covering the revenue growth of each sub-segment from 2018 to 2030.


Argentina’s heparin market is expected to show lucrative growth over the forecast period. According to data published by the U.S. FDA, bovine-sourced heparin is mostly manufactured and available in South America, especially in Argentina. 

Furthermore, the FDA encourages suppliers and manufacturers of bovine heparin to develop good manufacturing processes, along with the related quality control for their products. According to WHO, in 2016, around 28% of mortality cases were due to cardiovascular diseases in Argentina. 

As per The Lancet Neurology, in 2018, stroke in Argentina was the second-largest cause of death. Currently, stroke is not covered under social security or private healthcare, and therefore, additional costly policies specifically for stroke are required. All these factors are responsible for the growth of Argentina’s heparin market.

Reasons to subscribe to Argentina heparin market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Argentina heparin market databook

  • Our clientele includes a mix of heparin market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Argentina heparin market , including forecasts for subscribers. This country databook contains high-level insights into Argentina heparin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Argentina heparin market size, by source, 2018-2030 (US$M)

Argentina Heparin Market Outlook Share, 2023 & 2030 (US$M)

Argentina heparin market size, by source, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more